ARCHIVES

Politicians Applaud CPRIT’s New Direction; UT Gives Waiver To MD Anderson’s DePinho

This article is from The Cancer Letter archive.

Vol. 38 No. 40 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

January 25, 2002

DCT Board Committee Drawing Up Plans On How To Spend Biological Response Modifiers Money

August 31, 1979

12 Minority CCOPs Awardees Names, San Antonio Gets 2

September 21, 1990

In Brief: Bleyer To Chair Childrens Cancer Study Group; Fisher To Advise; Penn. Awards Herberman

May 3, 1991

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

October 3, 2014

DCT Concepts Approved

October 11, 1985